| Mangala Nadkarni, MD | |
|
200 S Orange Ave, Ste 101, Livingston, NJ 07039-5817 | |
| (973) 322-7580 | |
| (973) 322-7505 |
| Full Name | Mangala Nadkarni |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 42 Years |
| Location | 200 S Orange Ave, Livingston, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134231863 | NPI | - | NPPES |
| 5516609 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MA053598 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Barnabas Medical Center | Livingston, NJ | Hospital |
| Clara Maass Medical Center | Belleville, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Institute Of Neurology And Neurosurgery At Saint Barnabas | 4688560345 | 4 |
| Hudson Md Group | 6103240478 | 67 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
| Entity Name | Barnabas Health Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447206420 PECOS PAC ID: 0648172809 Enrollment ID: O20040127000361 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
| Entity Name | Institute Of Neurology And Neurosurgery At Saint Barnabas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386656270 PECOS PAC ID: 4688560345 Enrollment ID: O20040227000584 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
| Entity Name | Hudson Md Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497301998 PECOS PAC ID: 6103240478 Enrollment ID: O20200720001687 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mangala Nadkarni, MD 18 E 41st St, Ste 1206, New York, NY 10017-6222 Ph: (212) 725-8511 | Mangala Nadkarni, MD 200 S Orange Ave, Ste 101, Livingston, NJ 07039-5817 Ph: (973) 322-7580 |
News Archive
Clinuvel Pharmaceuticals Limited, a global biopharmaceutical company with unique expertise on the interaction of light and human skin, today announced positive results of its first US Phase II study of the novel photoprotective drug afamelanotide, known as SCENESSE.
Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room.
ANI Pharmaceuticals, Inc. today announced that it has acquired 22 previously marketed generic drug products from Teva Pharmaceuticals for $25 million in cash and a percentage of future gross profits from product sales. The acquisition includes 19 solid-oral dosage products, and 3 oral suspension products.
Methamphetamine users who described themselves as impulsive were more likely to have started taking the drug at an earlier age, a study of more than 150 users showed.
› Verified 3 days ago
Syed Fahim Alam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 107 E. Mt. Pleasant Ave, Suite 107, Livingston, NJ 07039 Phone: 973-535-3999 Fax: 973-535-3222 | |
Joseph S Sobelman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 22 Old Short Hills Rd, Suite 106, Livingston, NJ 07039 Phone: 973-994-1123 Fax: 973-994-7158 | |
Eric J. Bartky, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 513 W Mount Pleasant Ave, Suite 107, Livingston, NJ 07039 Phone: 973-533-1195 Fax: 973-533-1305 | |
Leonard Scott Eisenberg, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 340 E Northfield Rd, Suite 2a, Livingston, NJ 07039 Phone: 973-994-3455 Fax: 973-994-9191 | |
Michael Zornitzer, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2 W Northfield Rd, Suite 305, Livingston, NJ 07039 Phone: 973-992-6090 Fax: 973-992-1383 | |
Dr. Sherry Barron-seabrook, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 315 E Northfield Rd, Livingston, NJ 07039 Phone: 973-533-1209 Fax: 973-716-9688 | |
Dr. David Zeman, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 29 North Livingston Ave, Livingston, NJ 07039 Phone: 973-953-8580 Fax: 973-740-9362 |